Evaluation of the BioGX BD-Max PCR assay for detection of pathogenic Bordetella.

Pathology

Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, NSW, Australia; Sydney Medical School, The University of Sydney, NSW, Australia; Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology, Sydney, NSW, Australia.

Published: April 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2018.10.018DOI Listing

Publication Analysis

Top Keywords

evaluation biogx
4
biogx bd-max
4
bd-max pcr
4
pcr assay
4
assay detection
4
detection pathogenic
4
pathogenic bordetella
4
evaluation
1
bd-max
1
pcr
1

Similar Publications

Validation of a new extraction-free real-time PCR test to detect MPOX virus.

Diagn Microbiol Infect Dis

June 2024

Esoteric Testing/R&D Laboratory, Tampa General Hospital, 1 Tampa General Circle, Tampa, FL 33606, USA.

Article Synopsis
  • * The study assessed the BioGX Xfree hMPXV/OPXV test's ability to detect Mpox virus DNA in human samples using two different PCR platforms.
  • * Results showed that the Xfree hMPXV/OPXV test is sensitive and specific, with the pixl.16 platform offering benefits like a smaller size and quicker turnaround time due to its extraction-free process.
View Article and Find Full Text PDF

Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system.

J Clin Virol

October 2021

Tricore Reference Laboratory, 1001 Woodward Place, N.E., Albuquerque, NM 87102, USA. Electronic address:

Background: COVID-19 and influenza (flu) share similar clinical symptoms. Therefore, differential detection of these viruses during the respiratory virus season will be an important component for proper patient triage, management, and treatment.

Objectives: Establish the diagnostic performance related to SARS-CoV-2 and Flu A/B detection for the BD SARS-CoV-2/Flu for BD MAX™ System ("MAX SARS-CoV-2/Flu") multiplex assay.

View Article and Find Full Text PDF

Evaluation of the BioGX BD-Max PCR assay for detection of pathogenic Bordetella.

Pathology

April 2019

Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, NSW, Australia; Sydney Medical School, The University of Sydney, NSW, Australia; Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology, Sydney, NSW, Australia.

View Article and Find Full Text PDF

The Seegene Allplex Respiratory panel was retrospectively challenged using a collection of quality control samples (QCMD) and clinical samples previously analysed with validated routine methods. A collection of 111 samples [43 QCMD samples, 13 bronchoalveolar lavage fluids and 55 nasopharyngeal aspirates/swabs] was tested with Seegene Allplex. The clinical samples were tested previously using either FTD® Respiratory Pathogens 21 qPCR assay (Fast Track Diagnostics), an in-house multiplex PCR for , or BioGX Sample-Ready Atypical pneumo panel (Becton Dickinson).

View Article and Find Full Text PDF

Evaluation of the GeneXpert for Human Monkeypox Diagnosis.

Am J Trop Med Hyg

February 2017

Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Enteric and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Monkeypox virus (MPXV), a zoonotic orthopoxvirus (OPX), is endemic in the Democratic Republic of Congo (DRC). Currently, diagnostic assays for human monkeypox (MPX) focus on real-time quantitative polymerase chain reaction (PCR) assays, which are typically performed in sophisticated laboratory settings. Herein, we evaluated the accuracy and utility of a multiplex MPX assay using the GeneXpert platform, a portable rapid diagnostic device that may serve as a point-of-care test to diagnose infections in endemic areas.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!